Company
Ergomed PLC
LON:ERGO
Ergomed PLC provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval pharmacovigilance and medical information. The company's fast-growing services business includes an industry-leading suite of specialist pharmacovigilance (PV) solutions, integrated under the PrimeVigilance brand and a full range of high-quality clinical research and trial management services under the Ergomed brand (CRO).
204 stories · page 9 of 11
Proactive news round-up: Nostra Terra, Aureus Mining, ITM Power...
A round-up of today's news on the Proactive newswire
Ergomed celebrates fourth licensing deal for anti-cancer compound
Ergomed jointly developed Zoptrex with AEterna Zentaris
Ergomed upbeat as drug safety arm powers ahead
Miroslav Reljanovic, chief executive, said it had been an excellent first half.
Ergomed picks up €1.5mln contract through German acquisitions
The contract is worth €1.5mln and covers six countries.
Ergomed - German research house starts coverage with 'buy'
GBC says its predicted growth stems from the group's 'solid' positioning in the market
Ergomed completes recruitment for insomnia drug trial
The firm is developing the drug with partner Ferrer and has now attained 130 patients from 11 clinical sites across three European countries..
Ergomed secures two new licensing deals for cancer compound
The two agreements follow the 2014 license agreement with Sinopharm A-Think Pharmaceuticals Co.
Archive
Proactive news highlights: FairFX, Allergy Therapeutics, SalvaRx, Akers Biosciences, GW Pharma & more
Low-cost currency provider FairFX enjoyed its best ever week last week thanks to heightened trading activity amid the UK’s EU referendum vote.
Ergomed unit Prime Vigilance opening the doors in Boston
The expansion reflects the demand for PrimeVigilance’s services Stateside.
Ergomed strengthens services business with two bolt-ons
O+P will complement the existing European CRO (contract research) network while GASD will become the centre of excellence for data management
Proactive news highlights: Cello, Ergomed, ITM Power, KEFI Minerals, Metminco and more...
Rambler Metals and Mining commences a prefeasibility in Newfoundland, ITM Power hits the road and Union Jack expects more acquisitions.
Ergomed snaps up bleed halting specialist
Ergomed will pay an initial consideration of £8mln with milestone and sales based payments of up to £20mln
Archive
Proactive news highlights: Breedon Aggregates, Ergomed, Mariana Resources ...
Strong order pipeline for Ergomed, Breedon Aggregates plans to address concerns and Mariana Resources withdraws from its Suriname gold project.
Ergomed's hybrid strategy gives it plenty of ammo
The hybrid pharma services and drug development group has hit some key milestones over this year as trial results are eyed.
Ergomed has booked 85% of this year's revenues already
Turnover for the year to December 31 rose 43% to £30.2mln, while underlying earnings (EBITDA) were up 39% at £3.4mln.
Tuesday's agenda: UK to drive top-line growth at ASOS
The UK is still driving sales growth for ASOS, though Europe remains a key focus
Week ahead - ASOS, Ergomed and Optibiotix Health among AIM stocks reporting
There's a flurry of interesting small cap firms reporting this week, alongside AIM internet retail biggie ASOS....
Archive
Brokers: Kurdistan lift for Genel, Gulf Keystone says Barclays
Genel. Gulf Keystone, Just Eat, Premier Oil, Ergomed...
Ergomed eyes more drug deals as revenues rise
Turnover rose 25% and orders at the year-end were approximately £59mln.